Amended localization rules for pharma products and medical devices for public procurement purposes come into effect
On January 22, the amended Rules for Determining the Country of Origin of Certain Goods for Public (Municipal) Procurement Purposes will come into effect in the Eurasian Economic Union countries. They apply to relations arising from January 1, 2026.


The relevant decision of the Eurasian Economic Commission's Council dated November 19, 2025 adjusts the Rules in relation to certain types of pharmaceutical products and medical devices for public procurement. It is published on the EAEU legal portal.

The amendments will enable supplementing the Eurasian Register of Industrial Goods with 56 commodity items. Among them are 31 products including synthetic fibers, needles, prostheses, urostomy bags, ultrasound machines, medicines and pharmaceutical substances subject to complying with a list of production conditions and process operations. 25 products including medical masks, bandages, syringes, surgical materials, hearing aids and fire extinguishers will be included based on an ST-1 certificate.

Moreover, the validity period of Annex 11 to the Rules containing the list of goods included in the Eurasian Register of Industrial Goods upon provision of an ST-1 certificate is extended until the end of 2026. However, for some types of products the validity period is extended only until June 30, 2026.

   

The Eurasian Register of Industrial Goods is maintained for the purpose of ensuring access to public procurement in the EAEU countries where there are preferences, restrictions and prohibitions on goods originating other Member States and third countries. Inclusion into the Register requires a certain procedure to be followed.